PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AIM ImmunoTech Inc. (AIM)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS00901B1052
CUSIP00901B105
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$20.51M
EPS-$0.60
PEG Ratio0.90
Revenue (TTM)$202.00K
Gross Profit (TTM)-$715.00K
EBITDA (TTM)-$31.68M
Year Range$0.32 - $0.75
Target Price$3.50
Short %0.85%
Short Ratio1.42

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


AIM ImmunoTech Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in AIM ImmunoTech Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%200.00%400.00%600.00%800.00%December2024FebruaryMarchAprilMay
-99.97%
723.51%
AIM (AIM ImmunoTech Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

AIM ImmunoTech Inc. had a return of -6.82% year-to-date (YTD) and -14.58% in the last 12 months. Over the past 10 years, AIM ImmunoTech Inc. had an annualized return of -45.30%, while the S&P 500 had an annualized return of 10.87%, indicating that AIM ImmunoTech Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-6.82%11.56%
1 month-11.83%7.13%
6 months2.50%17.26%
1 year-14.58%26.92%
5 years (annualized)-41.04%13.56%
10 years (annualized)-45.30%10.87%

Monthly Returns

The table below presents the monthly returns of AIM, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-5.68%-3.61%17.75%-13.27%-6.82%
202367.74%-0.00%-17.31%11.63%-4.17%45.65%-7.46%-0.00%-25.81%0.00%2.17%-6.38%41.94%
2022-8.70%-15.48%49.30%-0.94%-13.33%-14.29%-6.41%-8.22%-13.43%-1.72%-28.07%-24.39%-66.30%
202113.41%11.33%0.44%-4.85%-4.63%4.37%-2.79%-1.44%-1.94%-11.39%-17.88%-37.41%-48.60%
202085.19%105.00%24.88%-18.75%34.62%-11.43%17.74%-22.95%-4.44%-3.72%-11.11%-2.72%231.48%
201927.78%-21.74%-11.11%31.25%-52.38%-0.23%-46.47%-23.40%-57.78%-34.21%-20.00%35.00%-93.18%
201842.86%-0.00%-20.00%-20.00%0.00%0.00%-9.38%-3.45%-17.86%0.00%-21.74%0.00%-48.57%
20170.00%-30.43%14.58%21.82%-11.94%-15.25%-16.00%-14.29%-11.11%-3.12%3.23%9.38%-49.28%
201612.50%55.56%-7.14%7.69%-14.29%-0.00%8.33%-6.41%-13.70%-22.22%-16.33%-15.85%-28.13%
2015-12.00%9.09%-4.17%13.04%-11.54%-13.04%-0.00%-10.00%-5.56%-23.53%-7.69%-33.33%-68.00%
201462.96%-9.09%0.00%-17.50%0.00%-6.06%-9.68%-3.57%18.52%-9.38%-10.34%-3.85%-7.41%
201312.00%-21.43%-13.64%15.79%-0.00%-0.00%4.55%-0.00%4.35%-8.33%-4.55%28.57%8.00%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AIM is 37, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of AIM is 3737
AIM (AIM ImmunoTech Inc.)
The Sharpe Ratio Rank of AIM is 3636Sharpe Ratio Rank
The Sortino Ratio Rank of AIM is 4141Sortino Ratio Rank
The Omega Ratio Rank of AIM is 4040Omega Ratio Rank
The Calmar Ratio Rank of AIM is 3636Calmar Ratio Rank
The Martin Ratio Rank of AIM is 3535Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for AIM ImmunoTech Inc. (AIM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


AIM
Sharpe ratio
The chart of Sharpe ratio for AIM, currently valued at -0.15, compared to the broader market-2.00-1.000.001.002.003.004.00-0.15
Sortino ratio
The chart of Sortino ratio for AIM, currently valued at 0.37, compared to the broader market-4.00-2.000.002.004.006.000.37
Omega ratio
The chart of Omega ratio for AIM, currently valued at 1.04, compared to the broader market0.501.001.502.001.04
Calmar ratio
The chart of Calmar ratio for AIM, currently valued at -0.13, compared to the broader market0.002.004.006.00-0.13
Martin ratio
The chart of Martin ratio for AIM, currently valued at -0.41, compared to the broader market-10.000.0010.0020.0030.00-0.41
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.34, compared to the broader market-2.00-1.000.001.002.003.004.002.34
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.31, compared to the broader market-4.00-2.000.002.004.006.003.31
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.41, compared to the broader market0.501.001.502.001.41
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.90, compared to the broader market0.002.004.006.001.90
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.93, compared to the broader market-10.000.0010.0020.0030.008.93

Sharpe Ratio

The current AIM ImmunoTech Inc. Sharpe ratio is -0.15. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of AIM ImmunoTech Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.15
2.34
AIM (AIM ImmunoTech Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


AIM ImmunoTech Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-100.00%
0
AIM (AIM ImmunoTech Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the AIM ImmunoTech Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AIM ImmunoTech Inc. was 100.00%, occurring on Dec 29, 2022. The portfolio has not yet recovered.

The current AIM ImmunoTech Inc. drawdown is 100.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Mar 10, 20005739Dec 29, 2022
-61%Sep 10, 1998110Feb 17, 1999258Feb 24, 2000368
-58%Oct 14, 199674Jan 28, 1997167Sep 25, 1997241
-48.84%Nov 21, 199794Apr 8, 199865Jul 13, 1998159
-40.91%Jul 16, 199619Aug 9, 19965Aug 16, 199624

Volatility

Volatility Chart

The current AIM ImmunoTech Inc. volatility is 20.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%December2024FebruaryMarchAprilMay
20.00%
3.10%
AIM (AIM ImmunoTech Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of AIM ImmunoTech Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items